The Experts below are selected from a list of 1440 Experts worldwide ranked by ideXlab platform
Prawat Padoongcharoen - One of the best experts on this subject based on the ideXlab platform.
-
high dose rate cobalt 60 after loading intracavitary therapy of the uterine cervical carcinoma in srinagarind hospital analysis of residual disease
Asian Pacific Journal of Cancer Prevention, 2012Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objectives: To evaluate residual disease in uterine cervical cancer patients treated with Teletherapy using combined high dose rate Cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, FIGO stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted and the outcomes analysed. The patients were treated using Teletherapy 50 Gy/25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions. Results: The study covered 141 patients with uterine cervical cancer. The mean age was 50.0 years with a range of 30-78 years. The mean tumor size was 4.1 cm in diameter (range 1-8 cm). Mean follow - up time was 2.94 years (range 1 month-6.92 years). The overall incidence of residual locoregional disease was 3.5%. Residual disease, according to stage IIB, IIIB and IVA was present in 2.78%, 3.37% and 50.0%. It was noted that there was no evidence of residual disease in stage IB and IIA cases. Conclusion: Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions resulted in overall 3.5% residual disease and a 96.5% complete response. The proposed recommendation for improving outcome is initiation of measurements for early detection of disease.
-
high dose rate cobalt 60 afterloading intracavitary therapy for cervical carcinoma in srinagarind hospital analysis of survival
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objective: To evaluate the actuarial survival rates in uterine cervical cancer patients treated with Teletherapy combined with high dose rate (HDR) cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations or FIGO), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients were treated with Teletherapy 50Gy/25 fractions, five fractions per week to the whole pelvis, together with HDR cobalt-60 afterloading brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions. Results:The study analysed the records of 141 patients with uterine cervical cancer with a mean age of 50.0 years (range 30-78). The mean tumor size was 4.1 cm in diameter (range 1-8). Mean follow-up time was 2.94 years (range 1 month - 6.92 years). The 5 year actuarial survival rates for patients with small size tumors less than 2 cm in diameter and tumor sizes larger than 2 cm in diameter were 100% and 63.2%. The overall 5 year survival rate was 63.3%. For cancer stages IB, IIB, IIIA and IIIB they were 100%, 80.3%, 100% and 54.8% and for squamous cell carcinoma and adenocarcinoma were 58.3% and 31.2%. Conclusion: Combined HDR cobalt-60 brachytherapy and external beam radiotherapy provide a useful modality in the treatment of uterine cervical cancer, feasible for developing countries. The approach demonstrated a slightly elevated radiation morbidity but was most effective in early stages and with small tumor sizes less than 2 cm in diameter.
-
high dose rate cobalt 60 afterloading intracavitary therapy of uterine cervical carcinomas in srinagarind hospital analysis of complications
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:OBJECTIVES To evaluate complications in uterine cervical cancer patients treated with Teletherapy combined with high dose rate(HDR) cobalt-60 brachytherapy. MATERIALS AND METHODS A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients received Teletherapy 50 Gy / 25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/ fraction weekly to point A for 2 fractions. RESULTS The study subjects were 141 patients with uterine cervical cancer. The mean age was 49 years with a range of 30-78. The mean tumor size was 4.1 cms in diameter (range 1-8 cms ). Mean follow-up time was 2.9 years (range 1 month - 6.9 years). The treatments resulted in a 96.5% complete response rates but morbidity rates of grade 1 and grade 2 radiation proctitis of 27.0%, and 10.6 %. The grade 1 and grade 2 radiation cystitis were 1.4%, and 1.4 %. At the level of grade 3 radiation complications, 0.71% of radiation proctitis and 0.71% small bowel obstruction were observed. The mean onset time to develop radiation proctitis after complete treatment was 15 months with a range of 6-61 months, for radiation cystitis was 30 months (range 9 - 47 months) and for small bowel obstruction was 53 months in the one case it occurred. CONCLUSION Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions for uterine cancer demonstrated a slightly higher incidence of grade 2 radiation proctitis. Therefore, treatment using HDR-60 brachytherapy less than 850 cGy per fractionation for decreasing the grade 2 and grade 3 radiation morbidity is recommended.
Montien Pesee - One of the best experts on this subject based on the ideXlab platform.
-
high dose rate cobalt 60 after loading intracavitary therapy of the uterine cervical carcinoma in srinagarind hospital analysis of residual disease
Asian Pacific Journal of Cancer Prevention, 2012Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objectives: To evaluate residual disease in uterine cervical cancer patients treated with Teletherapy using combined high dose rate Cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, FIGO stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted and the outcomes analysed. The patients were treated using Teletherapy 50 Gy/25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions. Results: The study covered 141 patients with uterine cervical cancer. The mean age was 50.0 years with a range of 30-78 years. The mean tumor size was 4.1 cm in diameter (range 1-8 cm). Mean follow - up time was 2.94 years (range 1 month-6.92 years). The overall incidence of residual locoregional disease was 3.5%. Residual disease, according to stage IIB, IIIB and IVA was present in 2.78%, 3.37% and 50.0%. It was noted that there was no evidence of residual disease in stage IB and IIA cases. Conclusion: Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions resulted in overall 3.5% residual disease and a 96.5% complete response. The proposed recommendation for improving outcome is initiation of measurements for early detection of disease.
-
high dose rate cobalt 60 afterloading intracavitary therapy for cervical carcinoma in srinagarind hospital analysis of survival
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objective: To evaluate the actuarial survival rates in uterine cervical cancer patients treated with Teletherapy combined with high dose rate (HDR) cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations or FIGO), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients were treated with Teletherapy 50Gy/25 fractions, five fractions per week to the whole pelvis, together with HDR cobalt-60 afterloading brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions. Results:The study analysed the records of 141 patients with uterine cervical cancer with a mean age of 50.0 years (range 30-78). The mean tumor size was 4.1 cm in diameter (range 1-8). Mean follow-up time was 2.94 years (range 1 month - 6.92 years). The 5 year actuarial survival rates for patients with small size tumors less than 2 cm in diameter and tumor sizes larger than 2 cm in diameter were 100% and 63.2%. The overall 5 year survival rate was 63.3%. For cancer stages IB, IIB, IIIA and IIIB they were 100%, 80.3%, 100% and 54.8% and for squamous cell carcinoma and adenocarcinoma were 58.3% and 31.2%. Conclusion: Combined HDR cobalt-60 brachytherapy and external beam radiotherapy provide a useful modality in the treatment of uterine cervical cancer, feasible for developing countries. The approach demonstrated a slightly elevated radiation morbidity but was most effective in early stages and with small tumor sizes less than 2 cm in diameter.
-
high dose rate cobalt 60 afterloading intracavitary therapy of uterine cervical carcinomas in srinagarind hospital analysis of complications
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:OBJECTIVES To evaluate complications in uterine cervical cancer patients treated with Teletherapy combined with high dose rate(HDR) cobalt-60 brachytherapy. MATERIALS AND METHODS A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients received Teletherapy 50 Gy / 25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/ fraction weekly to point A for 2 fractions. RESULTS The study subjects were 141 patients with uterine cervical cancer. The mean age was 49 years with a range of 30-78. The mean tumor size was 4.1 cms in diameter (range 1-8 cms ). Mean follow-up time was 2.9 years (range 1 month - 6.9 years). The treatments resulted in a 96.5% complete response rates but morbidity rates of grade 1 and grade 2 radiation proctitis of 27.0%, and 10.6 %. The grade 1 and grade 2 radiation cystitis were 1.4%, and 1.4 %. At the level of grade 3 radiation complications, 0.71% of radiation proctitis and 0.71% small bowel obstruction were observed. The mean onset time to develop radiation proctitis after complete treatment was 15 months with a range of 6-61 months, for radiation cystitis was 30 months (range 9 - 47 months) and for small bowel obstruction was 53 months in the one case it occurred. CONCLUSION Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions for uterine cancer demonstrated a slightly higher incidence of grade 2 radiation proctitis. Therefore, treatment using HDR-60 brachytherapy less than 850 cGy per fractionation for decreasing the grade 2 and grade 3 radiation morbidity is recommended.
Srichai Krusun - One of the best experts on this subject based on the ideXlab platform.
-
high dose rate cobalt 60 after loading intracavitary therapy of the uterine cervical carcinoma in srinagarind hospital analysis of residual disease
Asian Pacific Journal of Cancer Prevention, 2012Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objectives: To evaluate residual disease in uterine cervical cancer patients treated with Teletherapy using combined high dose rate Cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, FIGO stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted and the outcomes analysed. The patients were treated using Teletherapy 50 Gy/25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions. Results: The study covered 141 patients with uterine cervical cancer. The mean age was 50.0 years with a range of 30-78 years. The mean tumor size was 4.1 cm in diameter (range 1-8 cm). Mean follow - up time was 2.94 years (range 1 month-6.92 years). The overall incidence of residual locoregional disease was 3.5%. Residual disease, according to stage IIB, IIIB and IVA was present in 2.78%, 3.37% and 50.0%. It was noted that there was no evidence of residual disease in stage IB and IIA cases. Conclusion: Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/fraction, weekly to point A for 2 fractions resulted in overall 3.5% residual disease and a 96.5% complete response. The proposed recommendation for improving outcome is initiation of measurements for early detection of disease.
-
high dose rate cobalt 60 afterloading intracavitary therapy for cervical carcinoma in srinagarind hospital analysis of survival
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:Objective: To evaluate the actuarial survival rates in uterine cervical cancer patients treated with Teletherapy combined with high dose rate (HDR) cobalt-60 brachytherapy. Materials and Methods: A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations or FIGO), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients were treated with Teletherapy 50Gy/25 fractions, five fractions per week to the whole pelvis, together with HDR cobalt-60 afterloading brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions. Results:The study analysed the records of 141 patients with uterine cervical cancer with a mean age of 50.0 years (range 30-78). The mean tumor size was 4.1 cm in diameter (range 1-8). Mean follow-up time was 2.94 years (range 1 month - 6.92 years). The 5 year actuarial survival rates for patients with small size tumors less than 2 cm in diameter and tumor sizes larger than 2 cm in diameter were 100% and 63.2%. The overall 5 year survival rate was 63.3%. For cancer stages IB, IIB, IIIA and IIIB they were 100%, 80.3%, 100% and 54.8% and for squamous cell carcinoma and adenocarcinoma were 58.3% and 31.2%. Conclusion: Combined HDR cobalt-60 brachytherapy and external beam radiotherapy provide a useful modality in the treatment of uterine cervical cancer, feasible for developing countries. The approach demonstrated a slightly elevated radiation morbidity but was most effective in early stages and with small tumor sizes less than 2 cm in diameter.
-
high dose rate cobalt 60 afterloading intracavitary therapy of uterine cervical carcinomas in srinagarind hospital analysis of complications
Asian Pacific Journal of Cancer Prevention, 2010Co-Authors: Montien Pesee, Srichai Krusun, Prawat PadoongcharoenAbstract:OBJECTIVES To evaluate complications in uterine cervical cancer patients treated with Teletherapy combined with high dose rate(HDR) cobalt-60 brachytherapy. MATERIALS AND METHODS A retrospective study of uterine cervical cancer patients, stages IB-IVB (International Federation of Gynecologists and Obstetricians recommendations), treated by radiotherapy alone between April 1986 and December 1988 was conducted. The patients received Teletherapy 50 Gy / 25 fractions, five fractions per week to the whole pelvis together with HDR Cobalt -60 afterloading brachytherapy of 850 cGy/ fraction weekly to point A for 2 fractions. RESULTS The study subjects were 141 patients with uterine cervical cancer. The mean age was 49 years with a range of 30-78. The mean tumor size was 4.1 cms in diameter (range 1-8 cms ). Mean follow-up time was 2.9 years (range 1 month - 6.9 years). The treatments resulted in a 96.5% complete response rates but morbidity rates of grade 1 and grade 2 radiation proctitis of 27.0%, and 10.6 %. The grade 1 and grade 2 radiation cystitis were 1.4%, and 1.4 %. At the level of grade 3 radiation complications, 0.71% of radiation proctitis and 0.71% small bowel obstruction were observed. The mean onset time to develop radiation proctitis after complete treatment was 15 months with a range of 6-61 months, for radiation cystitis was 30 months (range 9 - 47 months) and for small bowel obstruction was 53 months in the one case it occurred. CONCLUSION Combined Teletherapy along with high dose rate Cobalt -60 brachytherapy of 850 cGy/ fraction, weekly to point A for 2 fractions for uterine cancer demonstrated a slightly higher incidence of grade 2 radiation proctitis. Therefore, treatment using HDR-60 brachytherapy less than 850 cGy per fractionation for decreasing the grade 2 and grade 3 radiation morbidity is recommended.
Holappa Mervi - One of the best experts on this subject based on the ideXlab platform.
-
/r/-virheiden puheterapiakuntoutus Äännekoulun nettiterapiassa – ajasta riippumaton etäterapiaratkaisu suomenkielisten lasten äännevirheiden kuntouttamiseen
Helsingfors universitet, 2020Co-Authors: Holappa MerviAbstract:Tavoitteet. Äännevirheet ovat lapsilla yleisimmin esiintyviä puheen häiriöitä, joilla voi kuntouttamattomana olla kauaskantoisia vaikutuksia yksilön elämänlaatuun. Rajallisten puheterapiaresurssien takia äännevirheet jäävät valitettavan usein vaille riittävää kuntoutusta. Kuntoutuspalveluiden saatavuuden maantieteellistä epätasa-arvoa on pyritty vähentämään erilaisten ajasta riippumattomien etäterapiaratkaisujen avulla. Esimerkiksi äännevirheiden kuntouttamiseen kehitetyn Äännekoulun nettiterapian tavoitteena on auttaa suomalaisia kuntia priorisoimaan rajallisia puheterapiaresursseja ja mahdollistaa jokaiselle suomalaiselle lapselle pääsy puheterapiakuntoutuksen pariin asuinpaikkaan katsomatta. Tutkimuksia etäpuheterapian hyödyntämisestä suomenkielisten lasten äännevirheiden kuntouttamisessa on tehty vain vähän. Tämän pro gradu -tutkielman tavoitteena oli tutkia, kuntoutuvatko lasten /r/-virheet Äännekoulun nettiterapiassa sekä selvittää mahdollisia kuntoutumiseen vaikuttavia tekijöitä. Menetelmät. Tutkimuksessa käytetty aineisto koostui viimeisen vuoden aikana (maaliskuu 2019 – huhtikuu 2020) Äännekoulun nettiterapiajaksolle osallistuneiden alle 10-vuotiaiden lasten (n=109) perustiedoista sekä puheterapeutin potilastietokanta Diariumiin tehdyistä käyntikirjauksista ja muistiinpanoista. Kaikki tutkimukseen osallistuneet lapset olivat Äännekoulun nettiterapiassa kuntouttamassa puheessa esiintyvää /r/-virhettä. Tietojen luovuttaminen pro gradu -tutkielmaa varten oli perheille vapaaehtoista. Kerätty aineisto luokiteltiin ja analysoitiin Mann-Whitney U -testin ja khiin neliö -testin avulla. Tulokset ja johtopäätökset. Yli puolet tutkimukseen osallistuneista lapsista oppi tuottamaan kielenkärkitäryn vähintään yksittäisenä äänteenä kolmen kuukauden harjoittelujakson aikana Äännekoulun nettiterapiassa. Lapset oppivat täryn keskimäärin kuudennella yhteydenottokerralla. Suurin osa lapsista oppi täryn dn dn dn -tärynhakuharjoituksen avulla. Tyttöjen ja poikien välillä ei ollut eroa täryn oppimisessa. Äännevirheen laatu, äännevirheen tyyppi, lapsen ikä, sukupuoli tai harjoittelun lähtötaso eivät vaikuttaneet puheessa esiintyvän /r/-virheen kuntoutumiseen. Yhteydenottojen määrä ohjaavaan puheterapeuttiin korreloi vahvasti saavutettujen harjoittelutuloksien kanssa. Lasten /r/-virheet kuntoutuvat Äännekoulun nettiterapiassa hyvin. Äänteen oppimiseen vaikuttaa merkittävästi tiivis yhteydenpito ohjaavaan puheterapeuttiin. Jatkossa olisi mielenkiintoista tutkia /r/-virheen kuntoutumiseen vaikuttavia tekijöitä laajemmin, sekä selvittää äännevirheiden kuntoutumiseen tarvittavan kotiharjoittelun määrää etäpuheterapiassa.Objective. Speech sound errors are the most common speech disorders in children that, without proper treatment, can have far-reaching effects on an individual’s quality of life. Due to limited speech therapy resources, speech sound disorders are often left without adequate treatment. In Finland, efforts have been made to reduce the geographical inequality in the availability of rehabilitation services through various time-independent Teletherapy solutions. For example, the mission of Äännekoulu is to help Finnish municipalities prioritize their limited resources and enable every child to have access to speech therapy services, regardless of their place of residence. There are only few studies focusing on the use of Teletherapy practicies in the treatment of speech sound disorders in Finnish-speaking children. The aim of this study was to examine whether Äännekoulu’s online therapy is an effective way to rehabilitate children's /r/-errors and to describe possible factors influencing rehabilitation results. Methods. The data used in the study consisted of demographic information and speech therapist’s notes and records on children under 10 years of age (n = 109) who participated in a three-month training period at Äännekoulu’s online therapy aiming to rehabilitate existing /r/-errors in their speech during March 2019 - April 2020. The notes and records were collected from the patient database Diarium. Participation in the study was voluntary. The collected data were categorized and analyzed using the Mann-Whitney U test and the chi-square test. Results and conclusions. More than half of the children learned to produce alveolar trill /r/ at least in isolation during a training period at Äännekoulu’s online therapy. On average children learned to produce the tongue trill on the sixth contact with the speech therapist. Most of the children learned to produce tongue trill through the dn dn dn -exercise. There was no significant difference between sexes in learning to produce the alveolar trill. The quality and the type of the speech sound error, age, sex or the children’s skill level in the beginning of the training period did not affect the rehabilitation of /r/-error. The number of contacts with the speech therapist strongly correlated with the results achieved in Teletherapy. Äännekoulu’s online therapy seems to be an effective way to treat children’s /r/-errors. Learning to produce the alveolar trill correctly is significantly affected by active collaboration with the speech therapist. Further research is needed to identify the factors influencing the rehabilitation of the /r/-errors. Future research should also concentrate on the at home practice needed to treat speech sound errors in Teletherapy
-
/r/-virheiden puheterapiakuntoutus Äännekoulun nettiterapiassa : ajasta riippumaton etäterapiaratkaisu suomenkielisten lasten äännevirheiden kuntouttamiseen
Helsingfors universitet, 2020Co-Authors: Holappa MerviAbstract:Tavoitteet. Äännevirheet ovat lapsilla yleisimmin esiintyviä puheen häiriöitä, joilla voi kuntouttamattomana olla kauaskantoisia vaikutuksia yksilön elämänlaatuun. Rajallisten puheterapiaresurssien takia äännevirheet jäävät valitettavan usein vaille riittävää kuntoutusta. Kuntoutuspalveluiden saatavuuden maantieteellistä epätasa-arvoa on pyritty vähentämään erilaisten ajasta riippumattomien etäterapiaratkaisujen avulla. Esimerkiksi äännevirheiden kuntouttamiseen kehitetyn Äännekoulun nettiterapian tavoitteena on auttaa suomalaisia kuntia priorisoimaan rajallisia puheterapiaresursseja ja mahdollistaa jokaiselle suomalaiselle lapselle pääsy puheterapiakuntoutuksen pariin asuinpaikkaan katsomatta. Tutkimuksia etäpuheterapian hyödyntämisestä suomenkielisten lasten äännevirheiden kuntouttamisessa on tehty vain vähän. Tämän pro gradu -tutkielman tavoitteena oli tutkia, kuntoutuvatko lasten /r/-virheet Äännekoulun nettiterapiassa sekä selvittää mahdollisia kuntoutumiseen vaikuttavia tekijöitä. Menetelmät. Tutkimuksessa käytetty aineisto koostui viimeisen vuoden aikana (maaliskuu 2019 – huhtikuu 2020) Äännekoulun nettiterapiajaksolle osallistuneiden alle 10-vuotiaiden lasten (n=109) perustiedoista sekä puheterapeutin potilastietokanta Diariumiin tehdyistä käyntikirjauksista ja muistiinpanoista. Kaikki tutkimukseen osallistuneet lapset olivat Äännekoulun nettiterapiassa kuntouttamassa puheessa esiintyvää /r/-virhettä. Tietojen luovuttaminen pro gradu -tutkielmaa varten oli perheille vapaaehtoista. Kerätty aineisto luokiteltiin ja analysoitiin Mann-Whitney U -testin ja khiin neliö -testin avulla. Tulokset ja johtopäätökset. Yli puolet tutkimukseen osallistuneista lapsista oppi tuottamaan kielenkärkitäryn vähintään yksittäisenä äänteenä kolmen kuukauden harjoittelujakson aikana Äännekoulun nettiterapiassa. Lapset oppivat täryn keskimäärin kuudennella yhteydenottokerralla. Suurin osa lapsista oppi täryn dn dn dn -tärynhakuharjoituksen avulla. Tyttöjen ja poikien välillä ei ollut eroa täryn oppimisessa. Äännevirheen laatu, äännevirheen tyyppi, lapsen ikä, sukupuoli tai harjoittelun lähtötaso eivät vaikuttaneet puheessa esiintyvän /r/-virheen kuntoutumiseen. Yhteydenottojen määrä ohjaavaan puheterapeuttiin korreloi vahvasti saavutettujen harjoittelutuloksien kanssa. Lasten /r/-virheet kuntoutuvat Äännekoulun nettiterapiassa hyvin. Äänteen oppimiseen vaikuttaa merkittävästi tiivis yhteydenpito ohjaavaan puheterapeuttiin. Jatkossa olisi mielenkiintoista tutkia /r/-virheen kuntoutumiseen vaikuttavia tekijöitä laajemmin, sekä selvittää äännevirheiden kuntoutumiseen tarvittavan kotiharjoittelun määrää etäpuheterapiassa.Objective. Speech sound errors are the most common speech disorders in children that, without proper treatment, can have far-reaching effects on an individual’s quality of life. Due to limited speech therapy resources, speech sound disorders are often left without adequate treatment. In Finland, efforts have been made to reduce the geographical inequality in the availability of rehabilitation services through various time-independent Teletherapy solutions. For example, the mission of Äännekoulu is to help Finnish municipalities prioritize their limited resources and enable every child to have access to speech therapy services, regardless of their place of residence. There are only few studies focusing on the use of Teletherapy practicies in the treatment of speech sound disorders in Finnish-speaking children. The aim of this study was to examine whether Äännekoulu’s online therapy is an effective way to rehabilitate children's /r/-errors and to describe possible factors influencing rehabilitation results. Methods. The data used in the study consisted of demographic information and speech therapist’s notes and records on children under 10 years of age (n = 109) who participated in a three-month training period at Äännekoulu’s online therapy aiming to rehabilitate existing /r/-errors in their speech during March 2019 - April 2020. The notes and records were collected from the patient database Diarium. Participation in the study was voluntary. The collected data were categorized and analyzed using the Mann-Whitney U test and the chi-square test. Results and conclusions. More than half of the children learned to produce alveolar trill /r/ at least in isolation during a training period at Äännekoulu’s online therapy. On average children learned to produce the tongue trill on the sixth contact with the speech therapist. Most of the children learned to produce tongue trill through the dn dn dn -exercise. There was no significant difference between sexes in learning to produce the alveolar trill. The quality and the type of the speech sound error, age, sex or the children’s skill level in the beginning of the training period did not affect the rehabilitation of /r/-error. The number of contacts with the speech therapist strongly correlated with the results achieved in Teletherapy. Äännekoulu’s online therapy seems to be an effective way to treat children’s /r/-errors. Learning to produce the alveolar trill correctly is significantly affected by active collaboration with the speech therapist. Further research is needed to identify the factors influencing the rehabilitation of the /r/-errors. Future research should also concentrate on the at home practice needed to treat speech sound errors in Teletherapy
Eduardo Rosenblatt - One of the best experts on this subject based on the ideXlab platform.
-
Radiotherapy capacity in European countries: An analysis of the Directory of Radiotherapy Centres (DIRAC) database
Lancet Oncology, 2013Co-Authors: Eduardo Rosenblatt, Joanna Izewska, Yavuz Anacak, Yaroslav Pynda, Mathieu Boniol, Pierre Scalliet, Philippe AutierAbstract:Summary Radiotherapy is used for cure or palliation in around half of patients with cancer. We analysed data on radiotherapy equipment in 33 European countries registered in the Directory of Radiotherapy Centres (DIRAC) database, managed by the International Atomic Energy Agency. As of July, 2012, Europe had 1286 active radiotherapy centres. The average number of Teletherapy machines per radiotherapy centre ranged from 1·2 to 7·0 in different countries. Nordic countries, the UK, the Netherlands, and Slovenia all have large centres with four to ten Teletherapy machines. Most western and southern European countries have several small centres with one or two machines, with few larger centres. The fragmentation in radiotherapy services that prevails in many European countries might affect the economic burden of radiotherapy and its quality. Eastern and southeastern European countries need to expand and modernise their radiotherapy equipment.
-
the international atomic energy agency iaea an active role in the global fight against cancer
Radiotherapy and Oncology, 2012Co-Authors: Eduardo Rosenblatt, Eduardo Zubizarreta, J Wondergem, Elena Fidarova, J IzewskaAbstract:The International Atomic Energy Agency (IAEA) is an independent, intergovernmental science and technology-based organization, in the United Nations, that serves as the global focal point for nuclear cooperation. Article II of the IAEA Statute states: ‘‘The Agency shall seek to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity throughout the world. It shall ensure, so far as it is able, that assistance provided by it or at its request or under its supervision or control is not used in such a way as to further any military purpose’’ [1]. In the particular area of radiotherapy, the IAEA has as its objective to enhance Member States’ capabilities to establish sound policies for radiotherapy and cancer treatment, and to ensure the effective, efficient and safe utilization of current and future radiotherapy technologies. Epidemiological projections indicate that if current trends continue, the global cancer burden will increase from 12.6 million new cases per year in 2008, to 16.9 million by 2020 [2]. Remarkably, 70% of these cases will be in the developing world where the number will grow from 5.2 million/year to 8.8 million/year by 2020 [3]. The Division of Human Health keeps a Directory of Radiotherapy Centres (DIRAC) [4] which contains data on centres providing radiotherapy services worldwide. This data base lists equipment (Teletherapy and brachytherapy), imaging and dosimetry, staffing and number of patients treated annually. According to our database, there are currently a total of 13.265 Teletherapy machines operational worldwide. Of them 245 are in low-income countries, 4.109 in middle-income and 8.911 in high-income countries. This disparity points to the fact that, according to current projections, the largest increase in cancer incidence will occur in countries and regions of the world that are poorly prepared to cope with it, even at current levels.
